Chat with us, powered by LiveChat
Toggle Mobile Navigation

Archive for the ‘Quality’ Category

Pfizer in Hot Water With FDA Over ESTRING Ad

A recent advertisement for Pfizer’s new hormonal therapy for postmenopausal patients, Estring, caught the attention of the FDA’s Office of Prescription Drug Promotion in a bad way. In this direct-to-consumer promotion, spokespeople for Estring, depicted in the ad as doctor and patient, discuss the new treatment, with the patient proclaiming that she had suffered no side effects. Unfortunately for Pfizer, any plausible side effects must be brought to the attention of consumers, even if this particular case showed none. This resulted in a chastising letter for Pfizer.

Though Pfizer might not agree, this story…

READ MORE


live chat software